TAX1BP3 and neoplasm: Recently, it has been reported that Tax1bp3 can be used as an appropriate target for tumour immunotherapy and imaging of cancers, and the monoclonal antibody against Tax1bp3 can be used as a radio‐immunoconjugate moiety to specifically image and treat tumours.15